syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.72054212187669
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687592
MOWAT-WILSON SYNDROME; MOWS	1.004112849	37.67044849469636
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.516150233723735
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.516150233723735
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	37.516150233723735
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	1.0	37.516150233723735
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	1.0	37.516150233723735
AMOEBIC KERATITIS	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
LAFORA DISEASE	0.7715289599999999	28.94479637302863
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.74803341	28.063333789404666
EARLY MYOCLONIC ENCEPHALOPATHY	0.7081833599999999	26.56831332678326
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7049018599999999	26.44520407979129
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.7041128490000002	26.415603424579242
PALLISTER-HALL SYNDROME	0.6827074999999999	25.612557135689944
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.5685520500000001	21.329884123491613
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.008600952602585
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.51630151	19.369645015058417
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.51330784	19.257334041588226
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.51057256	19.154716866176923
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.51057256	19.154716866176923
ACITRETIN/ETRETINATE EMBRYOPATHY	0.50840336	19.073336833089932
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.50357143	18.8920614212911
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.500541419	18.778387073405263
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
GIANT AXONAL NEUROPATHY	0.5	18.758075116861868
CREST SYNDROME	0.5	18.758075116861868
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.758075116861868
RESTRICTIVE DERMOPATHY	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
DUPLICATION OF THE PITUITARY GLAND	0.5	18.758075116861868
PAROXYSMAL HEMICRANIA	0.5	18.758075116861868
BRANCHIOOTORENAL SYNDROME 1	0.5	18.758075116861868
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4340692500000001	16.28460719483979
SHEEHAN SYNDROME	0.42590063	15.978152019717587
PANHYPOPHYSITIS	0.42232919999999996	15.844165715288359
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.4215423489999999	15.8146460949608
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064626
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41675494999999996	15.635041314848023
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062604
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39053901	14.651520171289736
CANAVAN DISEASE	0.37037	13.894856562064259
ADENOHYPOPHYSITIS	0.36677360000000003	13.759933479363697
FUNCTIONING GONADOTROPIC ADENOMA	0.365568	13.71470400864192
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
NON-FUNCTIONING PITUITARY ADENOMA	0.35620391900000004	13.363399739045162
CENTRALOPATHIC EPILEPSY	0.3547009	13.30701225243702
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3448273	12.936592791489327
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371794999999994	12.894974250227541
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070942
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.336043619	12.607062895488221
COG4-CDG	0.3355022	12.586750938944826
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	12.525682862401228
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPIDERMAL NEVUS SYNDROME	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31971448999999996	11.994456838738364
POST-TRAUMATIC PITUITARY DEFICIENCY	0.30306799999999995	11.369944619034184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.282451704428107
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.2970851	11.145489243800839
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.2970851	11.145489243800839
PANHYPOPITUITARISM	0.29600093	11.104815359201943
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.25668018000000004	9.629652194899252
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.2550844	9.569784672679278
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25357143	9.513023862860162
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430934
HEMOPHILIA B	0.25	9.379037558430934
SEVERE HEMOPHILIA A	0.25	9.379037558430934
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	9.379037558430934
PITUITARY APOPLEXY	0.24407850000000003	9.156885674821941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.2424996	9.097651425217913
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951174
TRICHOTHIODYSTROPHY	0.237037	8.892715702951174
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.22222260000000002	8.336936446928696
POLYARTERITIS NODOSA	0.2208333	8.284815259408983
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.22016199999999997	8.259630667757085
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21630151	8.114799944941298
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.213348919	8.004030097406556
MENINGIOMA	0.2098291	7.871980039007041
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.860522606725661
AUTOIMMUNE HYPOPARATHYROIDISM	0.20952369999999998	7.860522606725661
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20921145000000002	7.848808188815183
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002376
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	7.584610079831741
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	7.584610079831741
ROMANO-WARD SYNDROME	0.200541419	7.52354200328814
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
MALARIA	0.2	7.503230046744748
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.503230046744748
BENIGN SCHWANNOMA	0.2	7.503230046744748
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.503230046744748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.503230046744748
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744748
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.198071219	7.430869608980794
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.19536060000000002	7.329177619350411
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.1944448	7.294820328966366
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.18841599999999997	7.068642962437291
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.1877108	7.0421865732924696
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.86452884386067
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.7806787474422885
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.7806787474422885
CENTRAL CONGENITAL HYPOTHYROIDISM	0.17835963	6.691366674711379
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.17835963	6.691366674711379
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.1782665	6.6878727956401125
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.1713221	6.427345641957041
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.1713221	6.427345641957041
STICKLER SYNDROME	0.17071558	6.404591346517284
GANGLIOCYTOMA	0.17063479999999998	6.401560791901402
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.16988399999999998	6.3733936663059225
PROLACTINOMA	0.168169619	6.309076691152081
UNILATERAL POLYMICROGYRIA	0.16800169999999998	6.3027770167209844
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.167696819	6.2913390553215764
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.167208419	6.273016167547427
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.167208419	6.273016167547427
VICI SYNDROME; VICIS	0.167208419	6.273016167547427
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.273016167547427
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004034
STICKLER SYNDROME TYPE 1	0.166667	6.252704211004034
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004034
STICKLER SYNDROME TYPE 2	0.166667	6.252704211004034
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004034
SCHIZENCEPHALY	0.166667	6.252704211004034
MUCOLIPIDOSIS TYPE II	0.166667	6.252704211004034
STICKLER SYNDROME, TYPE II	0.166667	6.252704211004034
PANHYPOPITUITARISM, X-LINKED	0.1666666	6.25268920454394
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.1665464	6.248179763285847
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16361055999999996	6.13803834878367
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.156139849	5.857766032554939
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15435129999999997	5.790666559570561
WRINKLY SKIN SYNDROME	0.15435129999999997	5.790666559570561
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15349529999999997	5.758552734970494
PITUITARY STALK INTERRUPTION SYNDROME	0.15256841899999998	5.72377972812571
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.70681646315218
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15211625999999998	5.70681646315218
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155532
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	5.6747063901671355
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.440824707026065
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.1435898	5.3869365088303445
DE BARSY SYNDROME	0.14285699999999998	5.3594446739390715
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.3594446739390715
EHLERS-DANLOS SYNDROME, TYPE VI	0.14285699999999998	5.3594446739390715
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
CARNEY COMPLEX	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356097
CULLER-JONES SYNDROME; CJS	0.13813799999999998	5.182405960986129
FRONTORHINY	0.13813799999999998	5.182405960986129
PITUITARY CARCINOMA	0.13813799999999998	5.182405960986129
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.1303205	4.889123456533994
TSH-SECRETING PITUITARY ADENOMA	0.129708119	4.8661492789377165
ANE SYNDROME	0.1260229	4.727894049289543
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.125	4.689518779215467
RHOMBENCEPHALOSYNAPSIS	0.125	4.689518779215467
CRANIOTELENCEPHALIC DYSPLASIA	0.125	4.689518779215467
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.12174929999999999	4.5675650296507015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12037025999999999	4.515828757832387
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.11927242899999999	4.474642365105147
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11815324999999999	4.4326550776027185
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.425523257443287
NEPHROGENIC DIABETES INSIPIDUS	0.11739304899999999	4.404135262678892
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1152645	4.32428029861505
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.11165241899999999	4.1887689251626705
ISOLATED BILIARY ATRESIA	0.11165241899999999	4.1887689251626705
ACROMELIC FRONTONASAL DYSPLASIA	0.11165241899999999	4.1887689251626705
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1114059	4.179520481323204
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.11111099999999999	4.168456968619277
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.11111099999999999	4.168456968619277
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.11111099999999999	4.168456968619277
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.11111099999999999	4.168456968619277
EXUDATIVE VITREORETINOPATHY 4	0.11111099999999999	4.168456968619277
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.11111099999999999	4.168456968619277
NEPHROGENIC DIABETES INSIPIDUS - INTRACRANIAL CALCIFICATION	0.11111099999999999	4.168456968619277
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.11111099999999999	4.168456968619277
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.11111099999999999	4.168456968619277
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.11111099999999999	4.168456968619277
CYSTINOSIS	0.11111099999999999	4.168456968619277
SATOYOSHI SYNDROME	0.11111099999999999	4.168456968619277
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.11111099999999999	4.168456968619277
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.11111099999999999	4.168456968619277
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.11111099999999999	4.168456968619277
HYPERLIPOPROTEINEMIA, TYPE IV	0.11111099999999999	4.168456968619277
BARDET-BIEDL SYNDROME 1; BBS1	0.11111099999999999	4.168456968619277
PITUITARY DWARFISM IV	0.11111099999999999	4.168456968619277
RHYNS SYNDROME	0.11111099999999999	4.168456968619277
BILATERAL POLYMICROGYRIA	0.10628441000000001	3.98738189306269
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10625166	3.986153239142535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331000000002	3.984714494781073
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.10591140000000002	3.973387993864009
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10591140000000002	3.973387993864009
SCHINZEL-GIEDION SYNDROME	0.10591140000000002	3.973387993864009
PITUICYTOMA	0.10465540000000001	3.9262677091704514
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390427
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603113
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.10153924	3.8093613824581305
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.09997559999999998	3.7506996293066703
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326806
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.681154065810906
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.6708915229144705
CRANIOPHARYNGIOMA	0.09455851900000001	3.547471604682421
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09398854999999999	3.5260885620498548
HARTSFIELD SYNDROME; HRTFDS	0.09369369999999999	3.5150269251534416
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0925926	3.4737178921310883
HOLOPROSENCEPHALY	0.090744029	3.4043666247773836
NELSON SYNDROME	0.0858505	3.2207802556402996
SEPTOOPTIC DYSPLASIA	0.08491749999999999	3.1857776874722354
CHARGE SYNDROME	0.0794742	2.9815660269050066
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855681
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.077846419	2.9204979503614057
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.8858585760437547
PROLACTIN DEFICIENCY, ISOLATED	0.07692310000000001	2.8858585760437547
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.07692310000000001	2.8858585760437547
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.8858585760437547
WEBB-DATTANI SYNDROME; WEDAS	0.076668219	2.8762964221560323
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.07655338	2.871988104979342
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
GRANULOMATOSIS WITH POLYANGIITIS	0.075187419	2.8207425068899346
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.07418598	2.7831723709160245
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.07378314999999999	2.768059740117373
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07372048	2.7657086029822264
MELAS	0.07348576	2.7569028121993666
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7346876238384668
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483056
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07142860000000001	2.6797260885845593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07142860000000001	2.6797260885845593
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
EMANUEL SYNDROME	0.067317009	2.5254750229289327
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.067208119	2.5213898893299826
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.067208119	2.5213898893299826
ICHTHYOSIS AND MALE HYPOGONADISM	0.067208119	2.5213898893299826
MONOSOMY 18Q	0.067208119	2.5213898893299826
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.067208119	2.5213898893299826
PALLISTER-HALL SYNDROME	0.066735319	2.5036522534994785
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.50107793278659
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.0666667	2.50107793278659
ISOLATED FOLLICLE STIMULATING HORMONE DEFICIENCY	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.0666667	2.50107793278659
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.066612849	2.499057650580354
CONGENITAL HYPOTHYROIDISM	0.06644351	2.4927047032159253
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0663574	2.489474187519299
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0661939	2.4833402969560856
JOUBERT SYNDROME 26	0.0661939	2.4833402969560856
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0661939	2.4833402969560856
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121497
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.065147809	2.4440949898419393
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0645682	2.4223502915211212
MICROFORM HOLOPROSENCEPHALY	0.06450037900000001	2.41980590869612
ADNP SYNDROME	0.064436019	2.4173913692670768
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.064436019	2.4173913692670768
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0634556	2.38060982277108
KNOBLOCH SYNDROME	0.063041419	2.365071346151126
ACTH DEFICIENCY, ISOLATED; IAD	0.063041419	2.365071346151126
KNOBLOCH SYNDROME 1; KNO1	0.063041419	2.365071346151126
PETERS PLUS SYNDROME	0.06287208	2.3587183987866975
CHARGE SYNDROME	0.06287208	2.3587183987866975
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.06251996	2.3455082119663984
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.0625	2.3447593896077334
ENHANCED S-CONE SYNDROME	0.0625	2.3447593896077334
STICKLER SYNDROME, TYPE V; STL5	0.0625	2.3447593896077334
ADRENOCORTICAL CARCINOMA	0.0625	2.3447593896077334
MARSHALL SYNDROME	0.0625	2.3447593896077334
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0625	2.3447593896077334
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.0625	2.3447593896077334
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.0625	2.3447593896077334
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.0625	2.3447593896077334
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.0625	2.3447593896077334
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0625	2.3447593896077334
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0625	2.3447593896077334
KNIEST DYSPLASIA	0.0625	2.3447593896077334
WHITE-SUTTON SYNDROME; WHSUS	0.06129623000000001	2.299598573440884
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
KNIEST-LIKE DYSPLASIA, LETHAL	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.236119371437912
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.236119371437912
ENDOCARDIAL FIBROELASTOSIS	0.059364919	2.227143219816841
KALLMANN SYNDROME	0.059364919	2.227143219816841
TRIPLE A SYNDROME	0.059364919	2.227143219816841
GITELMAN SYNDROME	0.059127030000000004	2.2182185403538903
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.2182185403538903
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0588235	2.206831263273448
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0588235	2.206831263273448
SOMATOMAMMOTROPINOMA	0.0588235	2.206831263273448
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.0588235	2.206831263273448
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0588235	2.206831263273448
KEARNS-SAYRE SYNDROME	0.0588235	2.206831263273448
ACROMEGALY	0.0588235	2.206831263273448
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0588235	2.206831263273448
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0588235	2.206831263273448
BOHRING-OPITZ SYNDROME	0.058266219	2.1859242255550484
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0578905	2.171828695105384
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.057221599000000005	2.146734104697896
MEIER-GORLIN SYNDROME 1; MGORS1	0.056680180000000004	2.1264221481545036
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.056249549999999995	2.110266568379355
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.056097019000000005	2.1045441924680555
CRYPTOCOCCOSIS	0.056097019000000005	2.1045441924680555
HOLOPROSENCEPHALY 7	0.056097019000000005	2.1045441924680555
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.056097019000000005	2.1045441924680555
MALIGNANT ATROPHIC PAPULOSIS	0.056097019000000005	2.1045441924680555
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.055555600000000004	2.0842322359246626
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0842322359246626
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.055555600000000004	2.0842322359246626
OCULOCUTANEOUS ALBINISM TYPE 4	0.055555600000000004	2.0842322359246626
OCULOCUTANEOUS ALBINISM TYPE 1B	0.055555600000000004	2.0842322359246626
OCULOCUTANEOUS ALBINISM TYPE 2	0.055555600000000004	2.0842322359246626
OCULOCUTANEOUS ALBINISM TYPE 1A	0.055555600000000004	2.0842322359246626
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246626
HOLOPROSENCEPHALY 3; HPE3	0.055555600000000004	2.0842322359246626
HERMANSKY-PUDLAK SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.055555600000000004	2.0842322359246626
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.055555600000000004	2.0842322359246626
CONE-ROD DYSTROPHY 8; CORD8	0.055555600000000004	2.0842322359246626
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.055555600000000004	2.0842322359246626
FRIED SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
VACTERL WITH HYDROCEPHALUS	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.055555600000000004	2.0842322359246626
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.055555600000000004	2.0842322359246626
NEOVASCULAR GLAUCOMA	0.055555600000000004	2.0842322359246626
WOLFRAM-LIKE SYNDROME	0.055555600000000004	2.0842322359246626
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	2.0559150457282476
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0548008	2.0559150457282476
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.053173019	1.9948469691846469
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.053173019	1.9948469691846469
15Q OVERGROWTH SYNDROME	0.053173019	1.9948469691846469
AMISH INFANTILE EPILEPSY SYNDROME	0.05301935	1.9890818998943807
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.05268975000000001	1.9767165767773456
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0526316	1.9745350126412542
STEINERT MYOTONIC DYSTROPHY	0.0526316	1.9745350126412542
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9745350126412542
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412542
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412542
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.0526316	1.9745350126412542
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	1.9745350126412542
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412542
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9745350126412542
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9745350126412542
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9745350126412542
BIEMOND SYNDROME II	0.0526316	1.9745350126412542
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412542
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0526316	1.9745350126412542
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9745350126412542
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9745350126412542
PYGMY	0.0526316	1.9745350126412542
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9745350126412542
MYASTHENIA GRAVIS; MG	0.0526316	1.9745350126412542
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	1.9745350126412542
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.052208999000000006	1.9586806500363325
JOUBERT SYNDROME	0.052208999000000006	1.9586806500363325
SMITH-LEMLI-OPITZ SYNDROME	0.052208999000000006	1.9586806500363325
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.05197341900000001	1.949842595364272
CONGENITAL ANALBUMINEMIA	0.05188166	1.9464001509349755
SCHWARTZ-JAMPEL SYNDROME	0.051667580000000005	1.9383686934929403
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05073566	1.9034066427671283
JOUBERT SYNDROME WITH RENAL DEFECT	0.050329619	1.8881735476100767
JOUBERT SYNDROME WITH OCULAR DEFECT	0.050329619	1.8881735476100767
8P11.2 DELETION SYNDROME	0.050329619	1.8881735476100767
BETA-THALASSEMIA MAJOR	0.049788200000000005	1.8678615910666843
XQ21 MICRODELETION SYNDROME	0.049641219	1.8623474297891813
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.0490998	1.8420354732457886
RHYNS SYNDROME; RHYNS	0.0490998	1.8420354732457886
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.04869253	1.8267562707401
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510333
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379168
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.048160419	1.8067935145230831
MOSAIC TRISOMY 14	0.048160419	1.8067935145230831
EDINBURGH MALFORMATION SYNDROME	0.048160419	1.8067935145230831
2Q31.1 MICRODELETION SYNDROME	0.048160419	1.8067935145230831
SANJAD-SAKATI SYNDROME	0.048160419	1.8067935145230831
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.048160419	1.8067935145230831
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.048160419	1.8067935145230831
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.048160419	1.8067935145230831
AXENFELD-RIEGER SYNDROME	0.047619	1.7864815579796907
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.047619	1.7864815579796907
TRIPLOIDY	0.047619	1.7864815579796907
TETRAPLOIDY	0.047619	1.7864815579796907
CAMPOMELIA, CUMMING TYPE	0.047619	1.7864815579796907
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.047619	1.7864815579796907
HUMERO-RADIAL SYNOSTOSIS	0.047619	1.7864815579796907
CARTILAGE-HAIR HYPOPLASIA	0.047619	1.7864815579796907
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.047619	1.7864815579796907
DIABETIC EMBRYOPATHY	0.047619	1.7864815579796907
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.047619	1.7864815579796907
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.047619	1.7864815579796907
FANCONI ANEMIA	0.047619	1.7864815579796907
DISTAL TRISOMY 6P	0.047619	1.7864815579796907
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.047619	1.7864815579796907
OCULOMAXILLOFACIAL DYSOSTOSIS	0.047619	1.7864815579796907
DISTAL MONOSOMY 13Q	0.047619	1.7864815579796907
NON-DISTAL TRISOMY 13Q	0.047619	1.7864815579796907
XP22.3 MICRODELETION SYNDROME	0.047619	1.7864815579796907
DIENCEPHALIC SYNDROME	0.047619	1.7864815579796907
NON-DISTAL TRISOMY 10Q	0.047619	1.7864815579796907
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.047619	1.7864815579796907
CRANIOTELENCEPHALIC DYSPLASIA	0.047252199999999994	1.7727206340739605
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.045279599999999996	1.698716276122917
GABRIELE-DE VRIES SYNDROME	0.0451211	1.6927699663108722
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.6514503912503036
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503036
LASSA FEVER	0.044019719000000006	1.6514503912503036
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6514503912503036
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.04396649999999999	1.6494538192510142
DESMOSTEROLOSIS	0.04396649999999999	1.6494538192510142
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.641421611485974
WERNER SYNDROME	0.043478300000000004	1.631138434706911
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.631138434706911
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.631138434706911
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.631138434706911
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.631138434706911
ASHERMAN SYNDROME	0.043478300000000004	1.631138434706911
YELLOW FEVER	0.043478300000000004	1.631138434706911
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.631138434706911
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.631138434706911
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.631138434706911
PLACENTAL INSUFFICIENCY	0.043478300000000004	1.631138434706911
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.631138434706911
HYDATIDIFORM MOLE	0.043478300000000004	1.631138434706911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0430753	1.6160194261627199
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.042760718999999996	1.604217558106045
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.042721209999999996	1.6027353325264608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0427032	1.6020596666607514
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607514
COG2-CDG	0.041666699999999994	1.5631741769434964
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5631741769434964
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04152505	1.5578600142628898
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.04152505	1.5578600142628898
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.556034853554019
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.04145493	1.555229381808501
CHRISTIANSON SYNDROME	0.041085580000000003	1.5413727917196756
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041085580000000003	1.5413727917196756
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.040591519	1.5228375250190516
CHROMOSOME 1P36 DELETION SYNDROME	0.040419528999999996	1.5163851223403533
16P12.1P12.3 TRIPLICATION SYNDROME	0.0400501	1.5025255684756589
AICARDI SYNDROME	0.03987811	1.4960731657969608
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03923768	1.472046697702777
16P13.11 MICRODELETION SYNDROME	0.0392062	1.4708656892934193
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0392062	1.4708656892934193
HYDROLETHALUS	0.038706359999999995	1.4521136167605948
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.038706359999999995	1.4521136167605948
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0384615	1.4429274122143656
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0384615	1.4429274122143656
MENTAL RETARDATION, X-LINKED 98; MRX98	0.03838957899999999	1.4402292131734056
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.038140979	1.4309026982253021
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.428416165303961
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
ALSTROM SYNDROME; ALMS	0.0376653	1.4130570533982745
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.037345249999999997	1.4010500095159713
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.389485656206426
LISSENCEPHALY 2; LIS2	0.037037	1.389485656206426
WILLIAMS-BEUREN SYNDROME; WBS	0.03703181	1.389290947386713
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03623845	1.359527134437286
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
JUVENILE ABSENCE EPILEPSY	0.03566625	1.338060393273549
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.035188429	1.320134388852721
WOLFRAM SYNDROME	0.035188429	1.320134388852721
OCULOCEREBRORENAL SYNDROME OF LOWE	0.035188429	1.320134388852721
COG5-CDG	0.035024219	1.3139738618228414
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035024219	1.3139738618228414
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.035024219	1.3139738618228414
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.035024219	1.3139738618228414
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457724
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457724
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.293661905279449
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0344828	1.293661905279449
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0344828	1.293661905279449
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0344828	1.293661905279449
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	1.293661905279449
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0344828	1.293661905279449
CEREBROFACIOARTICULAR SYNDROME	0.0344828	1.293661905279449
OROFACIODIGITAL SYNDROME TYPE 14	0.0344828	1.293661905279449
PEHO SYNDROME	0.034427299999999994	1.291579758941477
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.034427299999999994	1.291579758941477
APERT SYNDROME	0.03435158	1.2887390360457796
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
DOORS SYNDROME	0.034069249999999995	1.278147101350292
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.033524649	1.257715768416856
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.033524649	1.257715768416856
TURNPENNY-FRY SYNDROME; TPFS	0.03346038	1.255304642957485
RAMOS-ARROYO SYNDROME	0.03346038	1.255304642957485
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03346038	1.255304642957485
SSR4-CDG	0.033013618999999994	1.2385438901629162
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.033013618999999994	1.2385438901629162
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.2374038118734636
300270 ADRENOMYODYSTROPHY	0.032983229999999995	1.2374038118734636
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.03247219999999999	1.2182319336195238
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.03247219999999999	1.2182319336195238
MARDEN-WALKER SYNDROME	0.03247219999999999	1.2182319336195238
TORIELLO-LACASSIE-DROSTE SYNDROME	0.03247219999999999	1.2182319336195238
SLC35A2-CDG	0.0322581	1.2101997258544837
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544837
ALG13-CDG	0.0322581	1.2101997258544837
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.2101997258544837
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.032122419	1.2051094970746217
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.032122419	1.2051094970746217
HOLMES-GANG SYNDROME	0.031581	1.1847975405312292
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.031581	1.1847975405312292
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.17151344689497
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
HOLOPROSENCEPHALY 2; HPE2	0.031139849	1.1682472533394719
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.030844418999999998	1.1571638570759228
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.030844418999999998	1.1571638570759228
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.030844418999999998	1.1571638570759228
RING CHROMOSOME 22 SYNDROME	0.030844418999999998	1.1571638570759228
WEAVER SYNDROME	0.030844418999999998	1.1571638570759228
WALKER-WARBURG SYNDROME	0.030844418999999998	1.1571638570759228
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0306127	1.1484706522599146
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03059843	1.1479352967960792
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.030302999999999997	1.1368519005325304
NEU-LAXOVA SYNDROME	0.030302999999999997	1.1368519005325304
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.030302999999999997	1.1368519005325304
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.030302999999999997	1.1368519005325304
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.030302999999999997	1.1368519005325304
HYDROLETHALUS SYNDROME 1	0.030302999999999997	1.1368519005325304
DISTAL 16P11.2 MICRODELETION SYNDROME	0.029953219	1.1237294639876283
PITT-HOPKINS-LIKE SYNDROME	0.029953219	1.1237294639876283
7Q11.23 MICRODUPLICATION SYNDROME	0.029953219	1.1237294639876283
16P13.2 MICRODELETION SYNDROME	0.029953219	1.1237294639876283
QAZI-MARKOUIZOS SYNDROME	0.029953219	1.1237294639876283
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.029953219	1.1237294639876283
FG SYNDROME TYPE 1	0.029465409	1.1054287107421155
CURRARINO SYNDROME	0.0294118	1.1034175074442356
AL AMYLOIDOSIS	0.0294118	1.1034175074442356
CURRY-JONES SYNDROME	0.0294118	1.1034175074442356
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.1034175074442356
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.1034175074442356
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.0941742408335005
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.027795809999999997	1.0427917838280405
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0427917838280405
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.027777800000000002	1.0421161179623313
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
PROTEUS SYNDROME	0.027568419	1.034260948910244
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.027568419	1.034260948910244
CENTRAL DIABETES INSIPIDUS	0.027568419	1.034260948910244
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.034260948910244
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.027568419	1.034260948910244
FABRY DISEASE	0.027568419	1.034260948910244
HOLOPROSENCEPHALY 1; HPE1	0.027568419	1.034260948910244
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.027568419	1.034260948910244
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668514
SARCOIDOSIS	0.027027	1.0139489923668514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668514
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0139489923668514
GROWTH HORMONE INSENSITIVITY SYNDROME	0.027027	1.0139489923668514
GIANT CELL ARTERITIS	0.027027	1.0139489923668514
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.027027	1.0139489923668514
14Q22Q23 MICRODELETION SYNDROME	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
ERDHEIM-CHESTER DISEASE	0.027027	1.0139489923668514
XANTHOMA DISSEMINATUM	0.027027	1.0139489923668514
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.025563699999999998	0.9590516097298434
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02488188	0.9334723481774859
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.907315337911529
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.023543919	0.8832772022946227
CHROMOSOME 19P13.13 DELETION SYNDROME	0.023231249000000002	0.8715470276010445
TEMPLE SYNDROME	0.023090239999999998	0.8662569127727371
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0230025	0.8629652457512302
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.02292276	0.8599737079315932
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.02258513	0.8473071301281809
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02206686	0.827863634946549
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818612
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818612
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818612
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818612
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076292
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021374719	0.8018971692076292
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.02099778	0.7877558690546796
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642366
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642366
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642366
CRANDALL SYNDROME	0.0208333	0.7815852126642366
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642366
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	0.7815852126642366
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642366
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642366
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642366
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7815852126642366
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642366
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642366
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642366
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7815852126642366
DERMOIDS OF CORNEA	0.0208333	0.7815852126642366
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642366
INFANTILE MYOFIBROMATOSIS	0.0208333	0.7815852126642366
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642366
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7815852126642366
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642366
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642366
IMINOGLYCINURIA	0.0208333	0.7815852126642366
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.7815852126642366
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642366
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642366
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642366
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642366
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642366
611426 TENTED EYEBROWS	0.0208333	0.7815852126642366
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642366
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642366
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642366
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642366
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642366
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642366
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689524
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751289
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
SALT-AND-PEPPER SYNDROME	0.02070575	0.7768000277019251
GAUCHER DISEASE	0.02035009	0.7634570337097991
16Q24.3 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718164
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.019659819000000002	0.7375607231718164
5Q14.3 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718164
19P13.13 MICRODELETION SYNDROME	0.019659819000000002	0.7375607231718164
2P15P16.1 MICRODELETION SYNDROME	0.0191184	0.717248766628424
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0191184	0.717248766628424
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01847071	0.6929499312835434
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.018288599	0.6861178276483297
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017747179999999998	0.6658058711049372
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01768055	0.6633061700148642
PHACE ASSOCIATION	0.017490619000000002	0.6561806900848229
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.017490619000000002	0.6561806900848229
PHACE SYNDROME	0.017490619000000002	0.6561806900848229
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.017490619000000002	0.6561806900848229
HYDRANENCEPHALY	0.017490619000000002	0.6561806900848229
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.017490619000000002	0.6561806900848229
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.017490619000000002	0.6561806900848229
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.017490619000000002	0.6561806900848229
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.017490619000000002	0.6561806900848229
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.017490619000000002	0.6561806900848229
8Q24.3 MICRODELETION SYNDROME	0.017490619000000002	0.6561806900848229
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.017490619000000002	0.6561806900848229
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.017490619000000002	0.6561806900848229
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.017490619000000002	0.6561806900848229
19P13.3 MICRODUPLICATION SYNDROME	0.01727003	0.647905040020916
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.01727003	0.647905040020916
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01723493	0.6465882231477122
HAREL-YOON SYNDROME; HAYOS	0.017094599999999998	0.6413235817854137
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.017094599999999998	0.6413235817854137
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.0169492	0.6358687335414304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0169492	0.6358687335414304
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.0169492	0.6358687335414304
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0169492	0.6358687335414304
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0169492	0.6358687335414304
MICROPHTHALMIA, SYNDROMIC 3	0.0169492	0.6358687335414304
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.0169492	0.6358687335414304
BRESEK SYNDROME	0.0169492	0.6358687335414304
MICROPHTHALMIA, ISOLATED 8	0.0169492	0.6358687335414304
STROMME SYNDROME; STROMS	0.0169492	0.6358687335414304
CRANIOSYNOSTOSIS 4; CRS4	0.0169492	0.6358687335414304
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0169492	0.6358687335414304
ANIRIDIA	0.0169492	0.6358687335414304
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0169492	0.6358687335414304
231970 GLUTEAL MUSCLES, ABSENCE OF	0.0169492	0.6358687335414304
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0169492	0.6358687335414304
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0169492	0.6358687335414304
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0169492	0.6358687335414304
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0169492	0.6358687335414304
JACOBSEN SYNDROME	0.016564789000000003	0.6214471127139345
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.016564789000000003	0.6214471127139345
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.015867799999999998	0.5952987686786814
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.015867799999999998	0.5952987686786814
WITTEVEEN-KOLK SYNDROME	0.015228299	0.5713071530880649
COHEN SYNDROME	0.015228299	0.5713071530880649
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5599435486984202
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984202
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984202
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984202
HYPOTONIA-CYSTINURIA SYNDROME	0.01468688	0.5509951965446724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014204918999999998	0.5329138752618766
SILVER-RUSSELL SYNDROME	0.01414399	0.5306280537442862
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5139187355916879
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916879
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916879
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
AYM-GRIPP SYNDROME	0.013698599999999998	0.5139187355916879
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5139187355916879
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.013698599999999998	0.5139187355916879
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013663499999999999	0.5126019187184843
PEHO-LIKE SYNDROME; PEHOL	0.013663499999999999	0.5126019187184843
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.013663499999999999	0.5126019187184843
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.013663499999999999	0.5126019187184843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.013663499999999999	0.5126019187184843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5126019187184843
HELSMOORTEL-VAN DER AA SYNDROME	0.013348918999999999	0.5008000506618091
WIEDEMANN-STEINER SYNDROME	0.013348918999999999	0.5008000506618091
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013348918999999999	0.5008000506618091
CORNELIA DE LANGE SYNDROME	0.012993359000000001	0.4874608082847065
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012993359000000001	0.4874608082847065
ZELLWEGER SYNDROME	0.012993359000000001	0.4874608082847065
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0128075	0.4804880941184167
LYSINURIC PROTEIN INTOLERANCE	0.0128075	0.4804880941184167
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0128075	0.4804880941184167
MEIER-GORLIN SYNDROME 6; MGORS6	0.0128075	0.4804880941184167
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0128075	0.4804880941184167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0128075	0.4804880941184167
KAGAMI-OGATA SYNDROME	0.012516209	0.46955997720068515
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012516209	0.46955997720068515
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012516209	0.46955997720068515
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012516209	0.46955997720068515
BECKWITH-WIEDEMANN SYNDROME	0.012451940000000002	0.467148851741314
CARDIOFACIOCUTANEOUS SYNDROME	0.012451940000000002	0.467148851741314
GMS SYNDROME	0.012451940000000002	0.467148851741314
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.012451940000000002	0.467148851741314
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748832
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01197479	0.44924802065729275
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	0.44924802065729275
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
BETA-UREIDOPROPIONASE DEFICIENCY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.011494299999999999	0.4312218856314908
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
FUMARASE DEFICIENCY; FMRD	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
PYRIDOXINE-DEPENDENT EPILEPSY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.4312218856314908
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.4312218856314908
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011494299999999999	0.4312218856314908
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01142846	0.42875182230010234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.01142846	0.42875182230010234
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.01142846	0.42875182230010234
KRABBE DISEASE	0.01142846	0.42875182230010234
SRD5A3-CDG	0.011179719	0.4194200175748157
PRADER-WILLI SYNDROME; PWS	0.011179719	0.4194200175748157
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011179719	0.4194200175748157
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.011179719	0.4194200175748157
MEHMO SYNDROME; MEHMO	0.011179719	0.4194200175748157
CHROMOSOME 18Q DELETION SYNDROME	0.011179719	0.4194200175748157
PRADER-WILLI SYNDROME	0.011179719	0.4194200175748157
DISTAL MONOSOMY 10Q	0.011113979	0.4169537058584507
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0106383	0.39910806103142327
EEC SYNDROME	0.0106383	0.39910806103142327
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0106383	0.39910806103142327
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0106383	0.39910806103142327
OLIVER-MCFARLANE SYNDROME	0.0106383	0.39910806103142327
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0106383	0.39910806103142327
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0106383	0.39910806103142327
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0106383	0.39910806103142327
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0106383	0.39910806103142327
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.0106383	0.39910806103142327
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0106383	0.39910806103142327
ACROOTOOCULAR SYNDROME	0.0106383	0.39910806103142327
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0106383	0.39910806103142327
WOODHOUSE-SAKATI SYNDROME	0.0106383	0.39910806103142327
SILVER-RUSSELL SYNDROME; SRS	0.0106383	0.39910806103142327
RITSCHER-SCHINZEL SYNDROME 1	0.0106383	0.39910806103142327
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0106383	0.39910806103142327
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.0106383	0.39910806103142327
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0106383	0.39910806103142327
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.0106383	0.39910806103142327
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0106383	0.39910806103142327
BOOMERANG DYSPLASIA	0.0106383	0.39910806103142327
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0106383	0.39910806103142327
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0106383	0.39910806103142327
BONNEMANN-MEINECKE-REICH SYNDROME	0.0106383	0.39910806103142327
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0106383	0.39910806103142327
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0106383	0.39910806103142327
TYSHCHENKO SYNDROME	0.01057256	0.3966417493150582
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01057256	0.3966417493150582
TEMPLE SYNDROME	0.01057256	0.3966417493150582
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01057256	0.3966417493150582
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565013
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.009800679	0.3676837457565013
MERRF	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.34737178921310885
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.34737178921310885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34737178921310885
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.34737178921310885
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00925926	0.34737178921310885
BIOTINIDASE DEFICIENCY	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 2	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.34737178921310885
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 3	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.00925926	0.34737178921310885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.34737178921310885
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34737178921310885
AMISH LETHAL MICROCEPHALY	0.00921145	0.34557814207043447
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00921145	0.34557814207043447
X SMALL RINGS	0.00921145	0.34557814207043447
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00921145	0.34557814207043447
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.33557367277145717
CONGENITAL TOXOPLASMOSIS	0.008944779	0.33557367277145717
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.33557367277145717
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.33557367277145717
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008944779	0.33557367277145717
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.33557367277145717
ADAMS-OLIVER SYNDROME	0.008944779	0.33557367277145717
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008944779	0.33557367277145717
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008944779	0.33557367277145717
GALLOWAY-MOWAT SYNDROME	0.008944779	0.33557367277145717
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33557367277145717
KAGAMI-OGATA SYNDROME	0.008944779	0.33557367277145717
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.008944779	0.33557367277145717
PELIZAEUS-MERZBACHER DISEASE	0.008944779	0.33557367277145717
INFANTILE SIALIC ACID STORAGE DISEASE	0.008944779	0.33557367277145717
FATCO SYNDROME	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3152617162280647
YUNIS-VARON SYNDROME	0.00840336	0.3152617162280647
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3152617162280647
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.3152617162280647
ROIFMAN SYNDROME; RFMN	0.00840336	0.3152617162280647
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3152617162280647
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.3152617162280647
DISTAL MONOSOMY 17Q	0.00840336	0.3152617162280647
NEMALINE MYOPATHY 10	0.00840336	0.3152617162280647
ROBERTS SYNDROME	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.3152617162280647
RENAL TUBULAR DYSGENESIS	0.00840336	0.3152617162280647
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3152617162280647
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3152617162280647
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3152617162280647
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.3152617162280647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3152617162280647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3152617162280647
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.3152617162280647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.3152617162280647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3152617162280647
CINCA SYNDROME	0.00840336	0.3152617162280647
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.3152617162280647
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
COSTELLO SYNDROME; CSTLO	0.00840336	0.3152617162280647
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3152617162280647
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.3152617162280647
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3152617162280647
RETINOPATHY OF PREMATURITY	0.00840336	0.3152617162280647
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3152617162280647
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3152617162280647
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3152617162280647
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.3152617162280647
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.3152617162280647
SCHISIS ASSOCIATION	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3152617162280647
EBSTEIN MALFORMATION	0.00840336	0.3152617162280647
VACTERL/VATER ASSOCIATION	0.00840336	0.3152617162280647
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3152617162280647
HEC SYNDROME	0.00840336	0.3152617162280647
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3152617162280647
OMPHALOCELE	0.00840336	0.3152617162280647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3152617162280647
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.3152617162280647
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3152617162280647
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.3152617162280647
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3152617162280647
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3152617162280647
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.3152617162280647
PEMPHIGOID GESTATIONIS	0.00840336	0.3152617162280647
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.008161429000000001	0.30618539648586973
PROPIONIC ACIDEMIA	0.008161429000000001	0.30618539648586973
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008161429000000001	0.30618539648586973
ANGELMAN SYNDROME	0.008161429000000001	0.30618539648586973
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008161429000000001	0.30618539648586973
48,XXYY SYNDROME	0.008161429000000001	0.30618539648586973
XQ28 (MECP2) DUPLICATION	0.008161429000000001	0.30618539648586973
SMITH-MAGENIS SYNDROME	0.008161429000000001	0.30618539648586973
RUBINSTEIN-TAYBI SYNDROME	0.008161429000000001	0.30618539648586973
1P36 DELETION SYNDROME	0.008161429	0.3061853964858697
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.008161429	0.3061853964858697
22Q11.2 DELETION SYNDROME	0.008161429	0.3061853964858697
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00762001	0.2858734399424772
FLOATING-HARBOR SYNDROME	0.00762001	0.2858734399424772
NIEMANN-PICK DISEASE, TYPE A	0.00762001	0.2858734399424772
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00762001	0.2858734399424772
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00762001	0.2858734399424772
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00762001	0.2858734399424772
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00762001	0.2858734399424772
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00762001	0.2858734399424772
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.264198108983441
1Q44 MICRODELETION SYNDROME	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
PELGER-HUET ANOMALY; PHA	0.00704225	0.264198108983441
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.264198108983441
OLIVER SYNDROME	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00704225	0.264198108983441
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.264198108983441
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.264198108983441
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
W SYNDROME	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.264198108983441
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.264198108983441
SARCOSINEMIA	0.00704225	0.264198108983441
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.264198108983441
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.264198108983441
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.264198108983441
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.264198108983441
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006282049	0.23567829405961396
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.006282049	0.23567829405961396
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006282049	0.23567829405961396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006282049	0.23567829405961396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.006282049	0.23567829405961396
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.006282049	0.23567829405961396
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.23567829405961396
PITT-HOPKINS SYNDROME	0.006282049	0.23567829405961396
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.006282049	0.23567829405961396
DESANTO-SHINAWI SYNDROME	0.006282049	0.23567829405961396
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.006282049	0.23567829405961396
EMANUEL SYNDROME	0.006282049	0.23567829405961396
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.23567829405961396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.23567829405961396
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006282049	0.23567829405961396
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006282049	0.23567829405961396
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.006282049	0.23567829405961396
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006282049	0.23567829405961396
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006282049	0.23567829405961396
SCHAAF-YANG SYNDROME; SHFYNG	0.006282049	0.23567829405961396
PRADER-WILLI-LIKE SYNDROME	0.006282049	0.23567829405961396
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006282049	0.23567829405961396
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00574063	0.21536633751622147
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00574063	0.21536633751622147
INFANTILE DYSTONIA-PARKINSONISM	0.00574063	0.21536633751622147
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21536633751622147
COFFIN-SIRIS SYNDROME 7; CSS7	0.00574063	0.21536633751622147
AU-KLINE SYNDROME; AUKS	0.00574063	0.21536633751622147
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.21536633751622147
ATHYREOSIS	0.00574063	0.21536633751622147
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00574063	0.21536633751622147
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00574063	0.21536633751622147
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00574063	0.21536633751622147
PERIPHERAL HYPOTHYROIDISM	0.00574063	0.21536633751622147
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00574063	0.21536633751622147
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00574063	0.21536633751622147
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00574063	0.21536633751622147
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00574063	0.21536633751622147
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00574063	0.21536633751622147
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21536633751622147
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21536633751622147
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00574063	0.21536633751622147
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004589999000000001	0.17219909205664174
FAMILIAL DYSAUTONOMIA	0.004589999000000001	0.17219909205664174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004589999000000001	0.17219909205664174
VICI SYNDROME	0.004589999000000001	0.17219909205664174
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.004589999000000001	0.17219909205664174
KABUKI SYNDROME 1	0.004589999000000001	0.17219909205664174
COFFIN-SIRIS SYNDROME	0.004589999000000001	0.17219909205664174
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004589999000000001	0.17219909205664174
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004589999000000001	0.17219909205664174
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004589999000000001	0.17219909205664174
COFS SYNDROME	0.004589999000000001	0.17219909205664174
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.004589999000000001	0.17219909205664174
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.004589999000000001	0.17219909205664174
21Q22.11Q22.12 MICRODELETION SYNDROME	0.004589999000000001	0.17219909205664174
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.004589999000000001	0.17219909205664174
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004589999000000001	0.17219909205664174
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004589999000000001	0.17219909205664174
GALACTOSEMIA	0.004589999000000001	0.17219909205664174
SOTOS SYNDROME	0.004589999000000001	0.17219909205664174
LISSENCEPHALY, X-LINKED, 2	0.004589999000000001	0.17219909205664174
ACROCARDIOFACIAL SYNDROME	0.004589999000000001	0.17219909205664174
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004589999000000001	0.17219909205664174
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004589999000000001	0.17219909205664174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.004589999000000001	0.17219909205664174
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.004589999000000001	0.17219909205664174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004589999000000001	0.17219909205664174
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004589999000000001	0.17219909205664174
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.004589999000000001	0.17219909205664174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004589999000000001	0.17219909205664174
FOLATE MALABSORPTION, HEREDITARY	0.004589999000000001	0.17219909205664174
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004589999000000001	0.17219909205664174
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.004589999000000001	0.17219909205664174
SYSTEMIC SCLEROSIS	0.004589999000000001	0.17219909205664174
OROFACIODIGITAL SYNDROME TYPE 6	0.004589999000000001	0.17219909205664174
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004589999000000001	0.17219909205664174
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004589999000000001	0.17219909205664174
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004589999000000001	0.17219909205664174
COFFIN-SIRIS SYNDROME 1; CSS1	0.004589999000000001	0.17219909205664174
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.004589999000000001	0.17219909205664174
NON-DISTAL MONOSOMY 20Q	0.004589999000000001	0.17219909205664174
COFFIN-LOWRY SYNDROME	0.004589999000000001	0.17219909205664174
OHDO SYNDROME	0.004589999000000001	0.17219909205664174
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004589999000000001	0.17219909205664174
COHEN SYNDROME	0.004589999000000001	0.17219909205664174
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.004589999000000001	0.17219909205664174
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.004589999000000001	0.17219909205664174
MENKES DISEASE	0.004589999000000001	0.17219909205664174
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004589999000000001	0.17219909205664174
MALAN OVERGROWTH SYNDROME	0.004589999000000001	0.17219909205664174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004589999000000001	0.17219909205664174
CANAVAN DISEASE	0.004589999000000001	0.17219909205664174
KOOLEN-DE VRIES SYNDROME; KDVS	0.004589999000000001	0.17219909205664174
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004589999000000001	0.17219909205664174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004589999000000001	0.17219909205664174
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004589999000000001	0.17219909205664174
SCLERODERMA	0.004589999000000001	0.17219909205664174
BOWEN-CONRADI SYNDROME	0.004589999000000001	0.17219909205664174
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004589999000000001	0.17219909205664174
CORNELIA DE LANGE SYNDROME 3	0.004589999000000001	0.17219909205664174
HYPOADRENOCORTICISM, FAMILIAL	0.004589999000000001	0.17219909205664174
POTOCKI-LUPSKI SYNDROME	0.004589999000000001	0.17219909205664174
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.004589999000000001	0.17219909205664174
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.004589999000000001	0.17219909205664174
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004589999000000001	0.17219909205664174
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004589999000000001	0.17219909205664174
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004589999000000001	0.17219909205664174
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.17219909205664174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.004589999000000001	0.17219909205664174
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.17219909205664174
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004589999000000001	0.17219909205664174
HYPOPHOSPHATASIA	0.004589999000000001	0.17219909205664174
NOONAN SYNDROME 7; NS7	0.004589999000000001	0.17219909205664174
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.004589999000000001	0.17219909205664174
PETERS-PLUS SYNDROME; PTRPLS	0.004589999000000001	0.17219909205664174
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004589999000000001	0.17219909205664174
ARGININOSUCCINIC ACIDURIA	0.004589999000000001	0.17219909205664174
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.004589999000000001	0.17219909205664174
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004589999000000001	0.17219909205664174
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.004589999000000001	0.17219909205664174
PEHO SYNDROME; PEHO	0.004589999000000001	0.17219909205664174
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004589999000000001	0.17219909205664174
SHASHI-PENA SYNDROME; SHAPNS	0.004589999000000001	0.17219909205664174
KOOLEN-DE VRIES SYNDROME	0.004589999000000001	0.17219909205664174
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.17219909205664174
MAPLE SYRUP URINE DISEASE; MSUD	0.004589999000000001	0.17219909205664174
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.004589999000000001	0.17219909205664174
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.004589999000000001	0.17219909205664174
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.004589999000000001	0.17219909205664174
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.004112849	0.15429826097262045
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.15429826097262045
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004112849	0.15429826097262045
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004112849	0.15429826097262045
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15429826097262045
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.004112849	0.15429826097262045
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262045
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262045
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262045
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004112849	0.15429826097262045
ALEXANDER DISEASE	0.004112849	0.15429826097262045
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004112849	0.15429826097262045
KLEEFSTRA SYNDROME	0.004112849	0.15429826097262045
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262045
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004112849	0.15429826097262045
9Q33.3Q34.11 MICRODELETION SYNDROME	0.004112849	0.15429826097262045
RETT SYNDROME; RTT	0.004112849	0.15429826097262045
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262045
TRISOMY 8P	0.004112849	0.15429826097262045
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004112849	0.15429826097262045
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.004112849	0.15429826097262045
FAMILIAL COLORECTAL CANCER TYPE X	0.004112849	0.15429826097262045
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004112849	0.15429826097262045
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262045
MOWAT-WILSON SYNDROME	0.004112849	0.15429826097262045
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004112849	0.15429826097262045
LYNCH SYNDROME	0.004112849	0.15429826097262045
TEMPLE-BARAITSER SYNDROME	0.004112849	0.15429826097262045
49,XXXXY SYNDROME	0.004112849	0.15429826097262045
48,XXXY SYNDROME	0.004112849	0.15429826097262045
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262045
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004112849	0.15429826097262045
DDOST-CDG	0.004112849	0.15429826097262045
PITT-HOPKINS SYNDROME	0.004112849	0.15429826097262045
611961 STEVENSON-CAREY SYNDROME	0.004112849	0.15429826097262045
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.004112849	0.15429826097262045
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262045
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262045
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262045
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004112849	0.15429826097262045
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262045
PORPHYRIA	0.004112849	0.15429826097262045
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.004112849	0.15429826097262045
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262045
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262045
KAPUR-TORIELLO SYNDROME	0.004112849	0.15429826097262045
SMITH-MAGENIS SYNDROME; SMS	0.004112849	0.15429826097262045
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004112849	0.15429826097262045
C SYNDROME	0.004112849	0.15429826097262045
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.15429826097262045
ADDISON DISEASE	0.004112849	0.15429826097262045
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262045
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004112849	0.15429826097262045
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004112849	0.15429826097262045
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.004112849	0.15429826097262045
GITELMAN SYNDROME	0.004112849	0.15429826097262045
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00404858	0.15188713551324926
DERMATOMYOSITIS	0.00404858	0.15188713551324926
CAFFEY DISEASE	0.00404858	0.15188713551324926
CAMURATI-ENGELMANN DISEASE	0.00404858	0.15188713551324926
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.15188713551324926
RING CHROMOSOME 1 SYNDROME	0.00404858	0.15188713551324926
ESOPHAGEAL ATRESIA	0.00404858	0.15188713551324926
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.15188713551324926
FREEMAN-SHELDON SYNDROME	0.00404858	0.15188713551324926
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00404858	0.15188713551324926
CHERUBISM	0.00404858	0.15188713551324926
AORTIC ARCH DEFECTS	0.00404858	0.15188713551324926
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.15188713551324926
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.15188713551324926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.15188713551324926
ALLAN-HERNDON-DUDLEY SYNDROME	0.00404858	0.15188713551324926
3C SYNDROME	0.00404858	0.15188713551324926
PEMPHIGUS VULGARIS	0.00404858	0.15188713551324926
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00404858	0.15188713551324926
PIERRE ROBIN SYNDROME	0.00404858	0.15188713551324926
STVE-WIEDEMANN SYNDROME	0.00404858	0.15188713551324926
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00404858	0.15188713551324926
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.15188713551324926
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00404858	0.15188713551324926
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.15188713551324926
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.15188713551324926
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00404858	0.15188713551324926
DUBOWITZ SYNDROME	0.00404858	0.15188713551324926
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.15188713551324926
MARTSOLF SYNDROME	0.00404858	0.15188713551324926
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.15188713551324926
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.15188713551324926
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.15188713551324926
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.15188713551324926
JOUBERT SYNDROME 10	0.00404858	0.15188713551324926
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.00404858	0.15188713551324926
NOONAN SYNDROME	0.00404858	0.15188713551324926
NEMALINE MYOPATHY 4	0.00404858	0.15188713551324926
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00404858	0.15188713551324926
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.15188713551324926
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00404858	0.15188713551324926
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.15188713551324926
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00404858	0.15188713551324926
JEUNE SYNDROME	0.00404858	0.15188713551324926
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.15188713551324926
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.15188713551324926
GOLDENHAR SYNDROME	0.00404858	0.15188713551324926
AICARDI-GOUTIERES SYNDROME 5	0.00404858	0.15188713551324926
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.15188713551324926
LEPRECHAUNISM	0.00404858	0.15188713551324926
WEAVER SYNDROME	0.00404858	0.15188713551324926
MOEBIUS SYNDROME	0.00404858	0.15188713551324926
INCLUSION BODY MYOSITIS	0.00404858	0.15188713551324926
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.15188713551324926
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.15188713551324926
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.15188713551324926
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.15188713551324926
MOEBIUS SYNDROME; MBS	0.00404858	0.15188713551324926
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.15188713551324926
MYOTONIC DYSTROPHY 1	0.00404858	0.15188713551324926
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.15188713551324926
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.00404858	0.15188713551324926
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.15188713551324926
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.15188713551324926
OCULOFACIOCARDIODENTAL SYNDROME	0.00404858	0.15188713551324926
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.15188713551324926
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00404858	0.15188713551324926
CRI-DU-CHAT SYNDROME	0.00404858	0.15188713551324926
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.15188713551324926
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.15188713551324926
TYPHOID	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.13398630442922796
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.13398630442922796
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.13398630442922796
PUDENDAL NEURALGIA	0.00357143	0.13398630442922796
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.13398630442922796
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13398630442922796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00357143	0.13398630442922796
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00357143	0.13398630442922796
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY	0.00357143	0.13398630442922796
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13398630442922796
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.13398630442922796
PROPIONIC ACIDEMIA	0.00357143	0.13398630442922796
PARATHYROID CARCINOMA	0.00357143	0.13398630442922796
FG SYNDROME 2; FGS2	0.00357143	0.13398630442922796
POLYMYOSITIS	0.00357143	0.13398630442922796
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.13398630442922796
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.13398630442922796
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13398630442922796
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13398630442922796
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.13398630442922796
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13398630442922796
MALT LYMPHOMA	0.00357143	0.13398630442922796
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13398630442922796
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13398630442922796
PURE AUTONOMIC FAILURE	0.00357143	0.13398630442922796
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13398630442922796
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13398630442922796
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13398630442922796
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13398630442922796
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13398630442922796
CAP POLYPOSIS	0.00357143	0.13398630442922796
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.13398630442922796
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13398630442922796
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00357143	0.13398630442922796
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13398630442922796
HIRSCHSPRUNG DISEASE	0.00357143	0.13398630442922796
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13398630442922796
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.13398630442922796
NEUROFERRITINOPATHY	0.00357143	0.13398630442922796
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13398630442922796
IATROGENIC BOTULISM	0.00357143	0.13398630442922796
INHALATIONAL BOTULISM	0.00357143	0.13398630442922796
ADIPOSIS DOLOROSA	0.00357143	0.13398630442922796
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13398630442922796
LIDDLE SYNDROME	0.00357143	0.13398630442922796
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.13398630442922796
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.13398630442922796
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.13398630442922796
FOODBORNE BOTULISM	0.00357143	0.13398630442922796
INFANT BOTULISM	0.00357143	0.13398630442922796
PSEUDOMYXOMA PERITONEI	0.00357143	0.13398630442922796
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13398630442922796
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13398630442922796
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13398630442922796
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.13398630442922796
ATTRV30M AMYLOIDOSIS	0.00357143	0.13398630442922796
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.13398630442922796
FAMILIAL THYROID DYSHORMONOGENESIS	0.00357143	0.13398630442922796
COFFIN-SIRIS SYNDROME 6; CSS6	0.00357143	0.13398630442922796
TOWNES-BROCKS SYNDROME	0.00357143	0.13398630442922796
UROFACIAL SYNDROME	0.00357143	0.13398630442922796
PPOMA	0.00357143	0.13398630442922796
GRFOMA	0.00357143	0.13398630442922796
WAARDENBURG-SHAH SYNDROME	0.00357143	0.13398630442922796
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00357143	0.13398630442922796
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00357143	0.13398630442922796
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.13398630442922796
PRUNE BELLY SYNDROME	0.00357143	0.13398630442922796
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.13398630442922796
WILLIAMS SYNDROME	0.00357143	0.13398630442922796
OCHOA SYNDROME	0.00357143	0.13398630442922796
VISCERAL MYOPATHY; VSCM	0.00357143	0.13398630442922796
THYROID ECTOPIA	0.00357143	0.13398630442922796
JUVENILE DERMATOMYOSITIS	0.00357143	0.13398630442922796
RHEUMATIC FEVER	0.00357143	0.13398630442922796
HINMAN SYNDROME	0.00357143	0.13398630442922796
KAPUR-TORIELLO SYNDROME	0.00357143	0.13398630442922796
THYROID HYPOPLASIA	0.00357143	0.13398630442922796
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.13398630442922796
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13398630442922796
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00357143	0.13398630442922796
SOMATOSTATINOMA	0.00357143	0.13398630442922796
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13398630442922796
MYXEDEMA	0.00357143	0.13398630442922796
NK-CELL ENTEROPATHY	0.00357143	0.13398630442922796
UROFACIAL SYNDROME 2	0.00357143	0.13398630442922796
BOTULISM	0.00357143	0.13398630442922796
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13398630442922796
THYROID HEMIAGENESIS	0.00357143	0.13398630442922796
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13398630442922796
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.13398630442922796
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13398630442922796
GLUCAGONOMA	0.00357143	0.13398630442922796
WOUND BOTULISM	0.00357143	0.13398630442922796
PORPHYRIA VARIEGATA	0.00357143	0.13398630442922796
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.13398630442922796
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
PALLISTER-KILLIAN SYNDROME	0.0027106189999999996	0.10169198963038599
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.10169198963038599
PHELAN-MCDERMID SYNDROME	0.0027106189999999996	0.10169198963038599
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0027106189999999996	0.10169198963038599
PIERPONT SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0027106189999999996	0.10169198963038599
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0027106189999999996	0.10169198963038599
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0027106189999999996	0.10169198963038599
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0027106189999999996	0.10169198963038599
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0027106189999999996	0.10169198963038599
MONOSOMY 22Q13.3	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027106189999999996	0.10169198963038599
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0027106189999999996	0.10169198963038599
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027106189999999996	0.10169198963038599
PMM2-CDG	0.0027106189999999996	0.10169198963038599
BOHRING-OPITZ SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0027106189999999996	0.10169198963038599
COCKAYNE SYNDROME	0.0027106189999999996	0.10169198963038599
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.10169198963038599
CRISPONI SYNDROME	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0027106189999999996	0.10169198963038599
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0027106189999999996	0.10169198963038599
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0027106189999999996	0.10169198963038599
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0027106189999999996	0.10169198963038599
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
GENITOPATELLAR SYNDROME	0.0027106189999999996	0.10169198963038599
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
MONOSOMY 9Q22.3	0.0027106189999999996	0.10169198963038599
GAUCHER DISEASE, TYPE II	0.0027106189999999996	0.10169198963038599
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0027106189999999996	0.10169198963038599
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0027106189999999996	0.10169198963038599
WIEACKER-WOLFF SYNDROME	0.0027106189999999996	0.10169198963038599
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0027106189999999996	0.10169198963038599
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 7	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0027106189999999996	0.10169198963038599
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0027106189999999996	0.10169198963038599
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0027106189999999996	0.10169198963038599
CHOREOACANTHOCYTOSIS	0.0027106189999999996	0.10169198963038599
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0027106189999999996	0.10169198963038599
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0027106189999999996	0.10169198963038599
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027106189999999996	0.10169198963038599
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027106189999999996	0.10169198963038599
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0027106189999999996	0.10169198963038599
KABUKI SYNDROME	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.10169198963038599
KBG SYNDROME	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027106189999999996	0.10169198963038599
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027106189999999996	0.10169198963038599
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0027106189999999996	0.10169198963038599
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0027106189999999996	0.10169198963038599
RFT1-CDG	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.10169198963038599
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0027106189999999996	0.10169198963038599
17Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0027106189999999996	0.10169198963038599
14Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0027106189999999996	0.10169198963038599
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.10169198963038599
ZTTK SYNDROME; ZTTKS	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027106189999999996	0.10169198963038599
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0027106189999999996	0.10169198963038599
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 5	0.0027106189999999996	0.10169198963038599
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.10169198963038599
ALG11-CDG	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0027106189999999996	0.10169198963038599
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027106189999999996	0.10169198963038599
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.10169198963038599
CITRULLINEMIA TYPE I	0.0027106189999999996	0.10169198963038599
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0027106189999999996	0.10169198963038599
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027106189999999996	0.10169198963038599
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0027106189999999996	0.10169198963038599
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027106189999999996	0.10169198963038599
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.10169198963038599
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0027106189999999996	0.10169198963038599
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.10169198963038599
RETINITIS PIGMENTOSA 59; RP59	0.0027106189999999996	0.10169198963038599
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0027106189999999996	0.10169198963038599
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0027106189999999996	0.10169198963038599
STT3A-CDG	0.0027106189999999996	0.10169198963038599
STT3B-CDG	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027106189999999996	0.10169198963038599
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.10169198963038599
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0027106189999999996	0.10169198963038599
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0027106189999999996	0.10169198963038599
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0027106189999999996	0.10169198963038599
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027106189999999996	0.10169198963038599
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.10169198963038599
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027106189999999996	0.10169198963038599
TETRASOMY 9P	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027106189999999996	0.10169198963038599
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 4; CSS4	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 3; CSS3	0.0027106189999999996	0.10169198963038599
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0027106189999999996	0.10169198963038599
COFFIN-SIRIS SYNDROME 2; CSS2	0.0027106189999999996	0.10169198963038599
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0027106189999999996	0.10169198963038599
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0027106189999999996	0.10169198963038599
DUPLICATION/INVERSION 15Q11	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027106189999999996	0.10169198963038599
PONTINE TEGMENTAL CAP DYSPLASIA	0.0027106189999999996	0.10169198963038599
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.08138003308699351
SANDIFER SYNDROME	0.0021691999999999996	0.08138003308699351
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.08138003308699351
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.08138003308699351
2Q32Q33 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
48,XYYY SYNDROME	0.0021691999999999996	0.08138003308699351
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0021691999999999996	0.08138003308699351
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.08138003308699351
16P11.2P12.2 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699351
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.08138003308699351
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.08138003308699351
ISOLATED COMPLEX I DEFICIENCY	0.0021691999999999996	0.08138003308699351
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.08138003308699351
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.08138003308699351
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699351
GALACTOSE EPIMERASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
EAR-PATELLA-SHORT STATURE SYNDROME	0.0021691999999999996	0.08138003308699351
INFANTILE SYSTEMIC HYALINOSIS	0.0021691999999999996	0.08138003308699351
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.08138003308699351
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.08138003308699351
ISOTRETINOIN-LIKE SYNDROME	0.0021691999999999996	0.08138003308699351
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.08138003308699351
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699351
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699351
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699351
LOCKED-IN SYNDROME	0.0021691999999999996	0.08138003308699351
HURLER SYNDROME	0.0021691999999999996	0.08138003308699351
SPINOCEREBELLAR ATAXIA TYPE 7	0.0021691999999999996	0.08138003308699351
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0021691999999999996	0.08138003308699351
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0021691999999999996	0.08138003308699351
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.08138003308699351
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.08138003308699351
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.08138003308699351
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0021691999999999996	0.08138003308699351
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.08138003308699351
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.08138003308699351
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
OROFACIODIGITAL SYNDROME TYPE 4	0.0021691999999999996	0.08138003308699351
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0021691999999999996	0.08138003308699351
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021691999999999996	0.08138003308699351
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.08138003308699351
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0021691999999999996	0.08138003308699351
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0021691999999999996	0.08138003308699351
BAKER-GORDON SYNDROME; BAGOS	0.0021691999999999996	0.08138003308699351
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.08138003308699351
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.08138003308699351
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.08138003308699351
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0021691999999999996	0.08138003308699351
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.08138003308699351
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699351
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.08138003308699351
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.08138003308699351
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021691999999999996	0.08138003308699351
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021691999999999996	0.08138003308699351
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0021691999999999996	0.08138003308699351
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.08138003308699351
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.08138003308699351
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0021691999999999996	0.08138003308699351
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0021691999999999996	0.08138003308699351
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 5; MGORS5	0.0021691999999999996	0.08138003308699351
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.08138003308699351
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.08138003308699351
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0021691999999999996	0.08138003308699351
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0021691999999999996	0.08138003308699351
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0021691999999999996	0.08138003308699351
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.08138003308699351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0021691999999999996	0.08138003308699351
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.08138003308699351
POPOV-CHANG SYNDROME; POPCHAS	0.0021691999999999996	0.08138003308699351
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0021691999999999996	0.08138003308699351
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.08138003308699351
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021691999999999996	0.08138003308699351
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0021691999999999996	0.08138003308699351
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0021691999999999996	0.08138003308699351
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0021691999999999996	0.08138003308699351
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.08138003308699351
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0021691999999999996	0.08138003308699351
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.08138003308699351
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.08138003308699351
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.08138003308699351
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0021691999999999996	0.08138003308699351
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.08138003308699351
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.08138003308699351
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.08138003308699351
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021691999999999996	0.08138003308699351
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021691999999999996	0.08138003308699351
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.08138003308699351
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021691999999999996	0.08138003308699351
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021691999999999996	0.08138003308699351
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021691999999999996	0.08138003308699351
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.08138003308699351
CRISS-CROSS HEART	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.08138003308699351
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0021691999999999996	0.08138003308699351
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.08138003308699351
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0021691999999999996	0.08138003308699351
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021691999999999996	0.08138003308699351
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.08138003308699351
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021691999999999996	0.08138003308699351
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0021691999999999996	0.08138003308699351
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0021691999999999996	0.08138003308699351
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.08138003308699351
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.08138003308699351
AURICULOCONDYLAR SYNDROME	0.0021691999999999996	0.08138003308699351
CHOANAL ATRESIA	0.0021691999999999996	0.08138003308699351
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.08138003308699351
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.08138003308699351
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392472
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392472
WYBURN-MASON SYNDROME	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392472
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392472
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392472
LEIGH SYNDROME	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392472
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.020311956543392472
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392472
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
PETTIGREW SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392472
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
MENKES DISEASE	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392472
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392472
AICARDI-GOUTIRES SYNDROME	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392472
CEDNIK SYNDROME	0.000541419	0.020311956543392472
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392472
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020311956543392472
NORRIE DISEASE	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000541419	0.020311956543392472
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.020311956543392472
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000541419	0.020311956543392472
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392472
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020311956543392472
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392472
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392472
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392472
MEND SYNDROME; MEND	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392472
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392472
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.020311956543392472
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
NARP SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392472
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392472
ALSTRM SYNDROME	0.000541419	0.020311956543392472
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.020311956543392472
NETHERTON SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392472
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.020311956543392472
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392472
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.020311956543392472
SCHINDLER DISEASE, TYPE I	0.000541419	0.020311956543392472
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392472
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.020311956543392472
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.020311956543392472
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020311956543392472
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.020311956543392472
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392472
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.020311956543392472
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392472
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020311956543392472
PGM3-CDG	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020311956543392472
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000541419	0.020311956543392472
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392472
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.020311956543392472
MEND SYNDROME	0.000541419	0.020311956543392472
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392472
GLASS SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
MAN1B1-CDG	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392472
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392472
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020311956543392472
CYCLIC VOMITING SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392472
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.020311956543392472
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392472
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
MUENKE SYNDROME	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.020311956543392472
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392472
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392472
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392472
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.020311956543392472
BAND HETEROTOPIA; BH	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
CODAS SYNDROME	0.000541419	0.020311956543392472
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392472
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
TIMOTHY SYNDROME; TS	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
LATHOSTEROLOSIS	0.000541419	0.020311956543392472
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020311956543392472
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
LATHOSTEROLOSIS	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392472
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392472
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.020311956543392472
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392472
SLC39A8-CDG	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
SALLA DISEASE	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.020311956543392472
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020311956543392472
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392472
CITRULLINEMIA, CLASSIC	0.000541419	0.020311956543392472
COACH SYNDROME	0.000541419	0.020311956543392472
COCKAYNE SYNDROME A; CSA	0.000541419	0.020311956543392472
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392472
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392472
COG8-CDG	0.000541419	0.020311956543392472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392472
BANGSTAD SYNDROME	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
C SYNDROME	0.000541419	0.020311956543392472
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
15Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
ARGININEMIA	0.000541419	0.020311956543392472
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392472
GAPO SYNDROME; GAPOS	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392472
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020311956543392472
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392472
HARTNUP DISORDER	0.000541419	0.020311956543392472
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392472
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392472
CROME SYNDROME	0.000541419	0.020311956543392472
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.020311956543392472
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.020311956543392472
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
SIALIDOSIS TYPE 2	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392472
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392472
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
MYHRE SYNDROME	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392472
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392472
HADDAD SYNDROME	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392472
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392472
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392472
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.020311956543392472
RECOMBINANT 8 SYNDROME	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392472
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392472
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392472
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392472
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392472
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
KBG SYNDROME	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
INSULINOMA	0.000541419	0.020311956543392472
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392472
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
CLASSIC PHENYLKETONURIA	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.020311956543392472
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000541419	0.020311956543392472
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392472
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.020311956543392472
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
PHENYLKETONURIA	0.000541419	0.020311956543392472
ELEJALDE DISEASE	0.000541419	0.020311956543392472
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000541419	0.020311956543392472
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392472
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
ALG1-CDG	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
DPM1-CDG	0.000541419	0.020311956543392472
ALG3-CDG	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392472
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
6Q TERMINAL DELETION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392472
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392472
ANGELMAN SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392472
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392472
INFANTILE REFSUM DISEASE	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
SULFOCYSTEINURIA	0.000541419	0.020311956543392472
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392472
RETT SYNDROME	0.000541419	0.020311956543392472
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020311956543392472
XYLOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020311956543392472
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
KRABBE DISEASE	0.000541419	0.020311956543392472
MEHMO SYNDROME	0.000541419	0.020311956543392472
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392472
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392472
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392472
KEUTEL SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392472
KETOADIPICACIDURIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392472
DPAGT1-CDG	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000541419	0.020311956543392472
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
SJGREN-LARSSON SYNDROME	0.000541419	0.020311956543392472
SIALIDOSIS TYPE 1	0.000541419	0.020311956543392472
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392472
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392472
47,XYY SYNDROME	0.000541419	0.020311956543392472
SCHIZENCEPHALY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
SANDHOFF DISEASE	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 1	0.000541419	0.020311956543392472
LEIGH SYNDROME; LS	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392472
TAY-SACHS DISEASE	0.000541419	0.020311956543392472
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
CAMOS SYNDROME	0.000541419	0.020311956543392472
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392472
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020311956543392472
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392472
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.020311956543392472
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
DUBOWITZ SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.020311956543392472
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392472
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392472
CITRULLINEMIA TYPE II	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020311956543392472
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392472
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392472
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.020311956543392472
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020311956543392472
LOWRY-MACLEAN SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000541419	0.020311956543392472
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392472
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020311956543392472
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392472
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392472
HYPEREKPLEXIA 4; HKPX4	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000541419	0.020311956543392472
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.020311956543392472
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392472
MOYNAHAN SYNDROME	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
MOMO SYNDROME	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392472
MICROSPORIDIOSIS	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
MONOSOMY 9P	0.000541419	0.020311956543392472
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
MIRAGE SYNDROME; MIRAGE	0.000541419	0.020311956543392472
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392472
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020311956543392472
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.020311956543392472
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000541419	0.020311956543392472
15Q14 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392472
LISSENCEPHALY 8; LIS8	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.020311956543392472
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392472
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392472
MICRO SYNDROME	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000541419	0.020311956543392472
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392472
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
6Q25 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392472
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.020311956543392472
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
19P13.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392472
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020311956543392472
8P23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392472
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392472
CK SYNDROME	0.000541419	0.020311956543392472
MATERNAL PHENYLKETONURIA	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392472
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392472
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392472
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392472
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392472
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020311956543392472
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392472
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
CADASIL	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392472
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392472
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392472
BEHET DISEASE	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392472
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.020311956543392472
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392472
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
2P21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392472
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392472
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
ROSA-DORFMAN DISEASE	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392472
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392472
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
CHDIAK-HIGASHI SYNDROME	0.000541419	0.020311956543392472
WOLCOTT-RALLISON SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392472
HENNEKAM SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392472
HARTNUP DISEASE	0.000541419	0.020311956543392472
HARROD SYNDROME	0.000541419	0.020311956543392472
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392472
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392472
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020311956543392472
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
OPTIC PATHWAY GLIOMA	0.000541419	0.020311956543392472
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392472
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392472
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020311956543392472
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392472
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392472
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
ATAXIA-TELANGIECTASIA	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
2Q37 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.020311956543392472
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392472
EAST SYNDROME	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.020311956543392472
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392472
COWDEN SYNDROME	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392472
XP21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392472
TETRASOMY 5P	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392472
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392472
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000541419	0.020311956543392472
TAKAYASU ARTERITIS	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
TETRASOMY 18P	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000541419	0.020311956543392472
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392472
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.020311956543392472
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
DISTAL TRISOMY 17Q	0.000541419	0.020311956543392472
TRISOMY 13	0.000541419	0.020311956543392472
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020311956543392472
TRISOMY X	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
FILIPPI SYNDROME	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.020311956543392472
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392472
RIFT VALLEY FEVER	0.000541419	0.020311956543392472
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392472
SIALURIA	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392472
RENPENNING SYNDROME	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.020311956543392472
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392472
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.020311956543392472
DISTAL MONOSOMY 15Q	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392472
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020311956543392472
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000541419	0.020311956543392472
HSD10 DISEASE	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.020311956543392472
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392472
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392472
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392472
GRISCELLI SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.020311956543392472
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
DISTAL MONOSOMY 1Q	0.000541419	0.020311956543392472
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
FUCOSIDOSIS	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
CHIME SYNDROME	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020311956543392472
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392472
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392472
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392472
WHIPPLE DISEASE	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
GLIOBLASTOMA	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020311956543392472
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.020311956543392472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.020311956543392472
LISSENCEPHALY 4	0.000541419	0.020311956543392472
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020311956543392472
GM1 GANGLIOSIDOSIS	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020311956543392472
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392472
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392472
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020311956543392472
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.020311956543392472
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.020311956543392472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.020311956543392472
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.020311956543392472
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.020311956543392472
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392472
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
L1 SYNDROME	0.000541419	0.020311956543392472
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.020311956543392472
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392472
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392472
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000541419	0.020311956543392472
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000541419	0.020311956543392472
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392472
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392472
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392472
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392472
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.020311956543392472
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020311956543392472
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020311956543392472
OCULODENTODIGITAL DYSPLASIA	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392472
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
TARP SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392472
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000541419	0.020311956543392472
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.020311956543392472
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392472
RUVALCABA SYNDROME	0.000541419	0.020311956543392472
NOCARDIOSIS	0.000541419	0.020311956543392472
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392472
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.020311956543392472
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020311956543392472
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020311956543392472
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392472
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392472
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392472
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392472
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392472
MEVALONIC ACIDURIA	0.000541419	0.020311956543392472
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392472
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392472
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392472
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392472
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020311956543392472
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
